Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/31738
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Spelman, Tim | - |
dc.contributor.author | Ozakbas, Serkan | - |
dc.contributor.author | Alroughani, Raed | - |
dc.contributor.author | Terzi, Murat | - |
dc.contributor.author | Hodgkinson, Suzanne | - |
dc.contributor.author | Laureys, Guy | - |
dc.contributor.author | Kalincik, Tomas | - |
dc.contributor.author | Van Der Walt, Anneke | - |
dc.contributor.author | Yamout, Bassem | - |
dc.contributor.author | Lechner-Scott, Jeannette | - |
dc.contributor.author | Soysal, Aysun | - |
dc.contributor.author | Kuhle, Jens | - |
dc.contributor.author | Sanchez-Menoyo, Jose Luis | - |
dc.contributor.author | Blanco Morgado, Yolanda | - |
dc.contributor.author | Spitaleri, Daniele LA | - |
dc.contributor.author | van Pesch, Vincent | - |
dc.contributor.author | Horakova, Dana | - |
dc.contributor.author | Ampapa, Radek | - |
dc.contributor.author | Patti, Francesco | - |
dc.contributor.author | Macdonell, Richard A L | - |
dc.contributor.author | Al-Asmi, Abdullah | - |
dc.contributor.author | Gerlach, Oliver | - |
dc.contributor.author | Oh, Jiwon | - |
dc.contributor.author | Altintas, Ayse | - |
dc.contributor.author | Tundia, Namita | - |
dc.contributor.author | Wong, Schiffon L | - |
dc.contributor.author | Butzkueven, Helmut | - |
dc.date | 2022-11 | - |
dc.date.accessioned | 2023-01-12T02:52:47Z | - |
dc.date.available | 2023-01-12T02:52:47Z | - |
dc.date.issued | 2023 | - |
dc.identifier.citation | Multiple Sclerosis Journal 2023 | en_US |
dc.identifier.issn | 1477-0970 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/31738 | - |
dc.description.abstract | Effectiveness of cladribine tablets, an oral disease-modifying treatment (DMT) for multiple sclerosis (MS), was established in clinical trials and confirmed with real-world experience. | en_US |
dc.language.iso | eng | - |
dc.subject | MS | en_US |
dc.subject | disability | en_US |
dc.subject | discontinuation | en_US |
dc.subject | real-world data | en_US |
dc.subject | registry | en_US |
dc.subject | relapse | en_US |
dc.subject | switching | en_US |
dc.title | Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Multiple Sclerosis Journal | en_US |
dc.identifier.affiliation | MSBase Foundation, Melbourne, VIC, Australia. | en_US |
dc.identifier.affiliation | Dokuz Eylul University, Izmir, Turkey. | en_US |
dc.identifier.affiliation | Al-Amiri Hospital, Kuwait City, Kuwait. | en_US |
dc.identifier.affiliation | Department of Neurology, 19 Mayis University, Samsun, Turkey. | en_US |
dc.identifier.affiliation | Liverpool Hospital, Sydney, NSW, Australia. | en_US |
dc.identifier.affiliation | University Hospital Ghent, Ghent, Belgium. | en_US |
dc.identifier.affiliation | MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia/CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia. | en_US |
dc.identifier.affiliation | Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia. | en_US |
dc.identifier.affiliation | Neurology Institute, Harley Street Medical Center, Abu Dhabi, United Arab Emirates/American University of Beirut Medical Center, Beirut, Lebanon. | en_US |
dc.identifier.affiliation | School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia/Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, NSW, Australia. | en_US |
dc.identifier.affiliation | Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey. | en_US |
dc.identifier.affiliation | Multiple Sclerosis Centre, Neurology, Departments of Head, Spine and Neuromedicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland/Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), University Hospital and University of Basel, Basel, Switzerland. | en_US |
dc.identifier.affiliation | Department of Neurology, Galdakao-Usansolo University Hospital, Osakidetza-Basque Health Service, Biocruces-Bizkaia Health Research Institute, Galdakao, Spain. | en_US |
dc.identifier.affiliation | Center of Neuroimmunology, Service of Neurology, Hospital Clinic de Barcelona, Barcelona, Spain. | en_US |
dc.identifier.affiliation | Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Ital. | en_US |
dc.identifier.affiliation | Cliniques Universitaires Saint-Luc (UCLouvain), Brussels, Belgium. | en_US |
dc.identifier.affiliation | Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic. | en_US |
dc.identifier.affiliation | Nemocnice Jihlava, Jihlava, Czech Republic. | en_US |
dc.identifier.affiliation | Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Catania, Italy. | en_US |
dc.identifier.affiliation | Neurology | en_US |
dc.identifier.affiliation | Neurology Unit, Department of Medicine, College of Medicine & Health Sciences and Sultan Qaboos University Hospital, Sultan Qaboos University (SQU), Al Khodh, Oman. | en_US |
dc.identifier.affiliation | Academic MS Center Zuyderland, Department of Neurology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands/School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands. | en_US |
dc.identifier.affiliation | Division of Neurology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. | en_US |
dc.identifier.affiliation | Koc University School of Medicine and Koc University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey. | en_US |
dc.identifier.affiliation | EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA. | en_US |
dc.identifier.doi | 10.1177/13524585221137502 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0001-9204-3216 | en_US |
dc.identifier.orcid | 0000-0001-5436-5804 | en_US |
dc.identifier.orcid | 0000-0003-3778-1376 | en_US |
dc.identifier.orcid | 0000-0002-4278-7003 | en_US |
dc.identifier.orcid | 0000-0002-3850-447X | en_US |
dc.identifier.orcid | 0000-0003-1915-0036 | en_US |
dc.identifier.orcid | 0000-0002-6923-0846 | en_US |
dc.identifier.orcid | 0000-0001-5519-6088 | en_US |
dc.identifier.pubmedid | 36433775 | - |
dc.description.startpage | 13524585221137502 | - |
local.name.researcher | Macdonell, Richard A L | |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
crisitem.author.dept | Neurology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.